<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="correction" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0146673</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-55554</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Herek</surname>
<given-names>Tyler A.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shew</surname>
<given-names>Timothy D.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Spurgin</surname>
<given-names>Heather N.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cutucache</surname>
<given-names>Christine E.</given-names>
</name>
</contrib>
</contrib-group>
<pub-date pub-type="epub">
<day>5</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<elocation-id>e0146673</elocation-id>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Herek et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0146673"/>
<related-article ext-link-type="uri" id="related001" related-article-type="corrected-article" xlink:href="info:doi/10.1371/journal.pone.0142682" xlink:type="simple">
<article-title>Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas</article-title>
</related-article>
<counts>
<fig-count count="0"/>
<table-count count="1"/>
<page-count count="2"/>
</counts>
</article-meta>
</front>
<body>
<p>In <xref ref-type="table" rid="pone.0146673.t001">Table 2</xref>, the AITL fold-change value column was inadvertently duplicated into the PTCL-NOS fold-change column. Please see the corrected <xref ref-type="table" rid="pone.0146673.t001">Table 2</xref> here.</p>
<table-wrap id="pone.0146673.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0146673.t001</object-id>
<label>Table 2</label> <caption><title>Genes significantly up- or down-regulated across all mature T-cell lymphoma subtypes as compared with healthy CD4<sup>+</sup> and CD8<sup>+</sup> T-cell controls.</title></caption>
<alternatives>
<graphic id="pone.0146673.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0146673.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene Name</th>
<th align="left">Symbol</th>
<th align="left">Chromosomal Location</th>
<th align="left">AITL Fold-Change</th>
<th align="left">ALCL Fold-Change</th>
<th align="left">ATLL Fold-Change</th>
<th align="left">HSTL Fold-Change</th>
<th align="left">PTCL-NOS Fold-Change</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Caveolin-1</td>
<td align="left">CAV1</td>
<td align="left">7q31.1</td>
<td align="left">16.33</td>
<td align="left">12.52</td>
<td align="left">38.17</td>
<td align="left">34.41</td>
<td align="left">17.03</td>
</tr>
<tr>
<td align="left">Cyclin B2</td>
<td align="left">CCNB2</td>
<td align="left">15q22.2</td>
<td align="left">7.55</td>
<td align="left">8.93</td>
<td align="left">13.99</td>
<td align="left">9.65</td>
<td align="left">10.81</td>
</tr>
<tr>
<td align="left">Thy-1 cell surface antigen</td>
<td align="left">THY1</td>
<td align="left">11q23.3</td>
<td align="left">13.65</td>
<td align="left">12.98</td>
<td align="left">9.46</td>
<td align="left">2.46</td>
<td align="left">9.88</td>
</tr>
<tr>
<td align="left">Tumor necrosis factor receptor superfamily member 21</td>
<td align="left">TNFRSF21</td>
<td align="left">6p21.1</td>
<td align="left">6.38</td>
<td align="left">6.27</td>
<td align="left">5.34</td>
<td align="left">9.30</td>
<td align="left">8.02</td>
</tr>
<tr>
<td align="left">Enabled homolog</td>
<td align="left">ENAH</td>
<td align="left">1q42.12</td>
<td align="left">5.62</td>
<td align="left">5.36</td>
<td align="left">2.52</td>
<td align="left">22.63</td>
<td align="left">5.32</td>
</tr>
<tr>
<td align="left">Presenilin 2</td>
<td align="left">PSEN2</td>
<td align="left">1q42.13</td>
<td align="left">2.94</td>
<td align="left">4.77</td>
<td align="left">2.26</td>
<td align="left">3.39</td>
<td align="left">3.09</td>
</tr>
<tr>
<td align="left">3g molecule, gamma (CD3-TCR complex)</td>
<td align="left">CD3G</td>
<td align="left">11q23</td>
<td align="left">-3.01</td>
<td align="left">-6.81</td>
<td align="left">-1.65</td>
<td align="left">-2.02</td>
<td align="left">-2.53</td>
</tr>
<tr>
<td align="left">Tumor necrosis factor receptor superfamily member 14</td>
<td align="left">TNFRSF14</td>
<td align="left">1p36.32</td>
<td align="left">-1.49</td>
<td align="left">-1.58</td>
<td align="left">-1.69</td>
<td align="left">-1.99</td>
<td align="left">-1.47</td>
</tr>
<tr>
<td align="left">RPTOR independent companion of MTOR, complex 2</td>
<td align="left">RICTOR</td>
<td align="left">5p13.1</td>
<td align="left">-2.42</td>
<td align="left">-4.36</td>
<td align="left">-1.75</td>
<td align="left">-2.25</td>
<td align="left">-2.03</td>
</tr>
<tr>
<td align="left">Linker for activation of T-cells</td>
<td align="left">LAT</td>
<td align="left">16p11.2</td>
<td align="left">-2.91</td>
<td align="left">-3.61</td>
<td align="left">-1.92</td>
<td align="left">-3.76</td>
<td align="left">-2.15</td>
</tr>
<tr>
<td align="left">CD5 molecule</td>
<td align="left">CD5</td>
<td align="left">11q13</td>
<td align="left">-4.12</td>
<td align="left">-6.55</td>
<td align="left">-2.10</td>
<td align="left">-17.27</td>
<td align="left">-3.98</td>
</tr>
<tr>
<td align="left">Interleukin 23, alpha subunit p19</td>
<td align="left">IL23A</td>
<td align="left">12q13.3</td>
<td align="left">-3.26</td>
<td align="left">-3.50</td>
<td align="left">-2.23</td>
<td align="left">-4.51</td>
<td align="left">-3.23</td>
</tr>
<tr>
<td align="left">IL2-inducible T-cell kinase</td>
<td align="left">ITK</td>
<td align="left">5q31-q32</td>
<td align="left">-3.67</td>
<td align="left">-10.78</td>
<td align="left">-2.36</td>
<td align="left">-2.70</td>
<td align="left">-3.82</td>
</tr>
<tr>
<td align="left">Signal transducer and activator of transcription 5A</td>
<td align="left">STAT5A</td>
<td align="left">17q11.2</td>
<td align="left">-2.14</td>
<td align="left">-2.11</td>
<td align="left">-2.50</td>
<td align="left">-2.63</td>
<td align="left">-2.27</td>
</tr>
<tr>
<td align="left">TSC22 domain family, member 3</td>
<td align="left">TSC22D3</td>
<td align="left">Xq22.3</td>
<td align="left">-5.66</td>
<td align="left">-6.63</td>
<td align="left">-2.56</td>
<td align="left">-4.07</td>
<td align="left">-4.99</td>
</tr>
<tr>
<td align="left">Ubiquitin-associated and SH3 domain-containing protein A</td>
<td align="left">UBASH3A</td>
<td align="left">21q22.3</td>
<td align="left">-2.43</td>
<td align="left">-4.27</td>
<td align="left">-2.86</td>
<td align="left">-6.97</td>
<td align="left">-2.46</td>
</tr>
<tr>
<td align="left">Protein kinase C theta</td>
<td align="left">PRKCQ</td>
<td align="left">10p15</td>
<td align="left">-2.98</td>
<td align="left">-8.26</td>
<td align="left">-3.58</td>
<td align="left">-2.92</td>
<td align="left">-3.86</td>
</tr>
<tr>
<td align="left">Forkhead box P1</td>
<td align="left">FOXP1</td>
<td align="left">3p14.1</td>
<td align="left">-4.90</td>
<td align="left">-3.96</td>
<td align="left">-3.69</td>
<td align="left">-3.40</td>
<td align="left">-3.84</td>
</tr>
<tr>
<td align="left">Phosphoprotein membrane anchor with glycosphingolipid microdomains 1</td>
<td align="left">PAG1</td>
<td align="left">8q21.13</td>
<td align="left">-3.81</td>
<td align="left">-2.32</td>
<td align="left">-4.30</td>
<td align="left">-3.69</td>
<td align="left">-2.63</td>
</tr>
<tr>
<td align="left">B-cell CLL/lymphoma 10</td>
<td align="left">BCL10</td>
<td align="left">1p22</td>
<td align="left">-4.96</td>
<td align="left">-7.82</td>
<td align="left">-6.54</td>
<td align="left">-7.15</td>
<td align="left">-6.26</td>
</tr>
<tr>
<td align="left">Phosphodiesterase 4B, cAMP-specific</td>
<td align="left">PDE4B</td>
<td align="left">1p31</td>
<td align="left">-4.21</td>
<td align="left">-3.55</td>
<td align="left">-7.44</td>
<td align="left">-3.42</td>
<td align="left">-2.45</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large cell lymphoma; ATLL, adult T-cell leukemia/lymphoma; HSTL, hepatosplenic T-cell lymphoma; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified</p></fn>
</table-wrap-foot>
</table-wrap>
</body>
<back>
<ref-list>
<title>Reference</title>
<ref id="pone.0146673.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herek</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Shew</surname> <given-names>TD</given-names></name>, <name name-style="western"><surname>Spurgin</surname> <given-names>HN</given-names></name>, <name name-style="western"><surname>Cutucache</surname> <given-names>CE</given-names></name> (<year>2015</year>) <article-title>Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas</article-title>. <source>PLoS ONE</source> <volume>10</volume>(<issue>11</issue>): <fpage>e0142682</fpage>. <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0142682" xlink:type="simple">10.1371/journal.pone.0142682</ext-link></comment> <object-id pub-id-type="pmid">26566034</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>